Laboratory Of America Holdings logo

LH - Laboratory Of America Holdings News Story

$260.51 -1.7  -0.6%

Last Trade - 19/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £18.18bn
Enterprise Value £21.46bn
Revenue £10.00bn
Position in Universe 486th / 6849

BRIEF-Adaptive Biotechnologies Expands Collaboration With Labcorp To Increase Access To Growing Research And Clinical Diagnostic Portfolio

Tue 23rd February, 2021 2:29pm
Feb 23 (Reuters) - Adaptive Biotechnologies Corp  ADPT.O :
    * ADAPTIVE BIOTECHNOLOGIES EXPANDS COLLABORATION WITH
LABCORP TO
INCREASE ACCESS TO GROWING RESEARCH AND CLINICAL DIAGNOSTIC
PORTFOLIO
    * ADAPTIVE BIOTECHNOLOGIES CORP - EXPANDED COLLABORATION
INCLUDES
A COMMERCIAL AGREEMENT FOR ADAPTIVE'S CLONOSEQ, IMMUNOSEQ ASSAYS
    * ADAPTIVE BIOTECHNOLOGIES CORP - EXPANDED COLLABORATION
INCLUDES
A LAB SERVICES AGREEMENT FOR ADAPTIVE'S RECENTLY LAUNCHED
T-DETECT COVID TEST
    * ADAPTIVE BIOTECHNOLOGIES CORP - LABCORP'S ONCOLOGY SALES
FORCE
WILL PROMOTE CLONOSEQ AT HEMATOLOGY-ONCOLOGY CLINICS IN U.S.
    * ADAPTIVE BIOTECHNOLOGIES - LABCORP IS PREPARING TO PERFORM
T-DETECT COVID AS A SECONDARY SITE LABORATORY ONCE TEST HAS
RECEIVED EUA FROM FDA

Source text for Eikon:  ID:nGNX3WhWMr 
Further company coverage:  ADPT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.